BIOS NASDAQ
BioPlus Acquisition Corp.
1W: +0.0%
1M: +0.2%
3M: +1.3%
1Y: +7.5%
$10.79
Last traded 2023-10-13 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$209.1M
52W Range10.12-11.68
Volume5,636
Avg Volume37,378
Beta0.00
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOR. Ross Haghighat
SectorFinancial Services
IndustryShell Companies
IPO Date2022-01-28
Websitebioplusspac.com
260 Madison Avenue
New York City, NY 10026
US
New York City, NY 10026
US
212 287 4092
About BioPlus Acquisition Corp.
Currently, BioPlus Acquisition Corp. possesses no major active business operations. Its express mandate is to pursue and complete a strategic combination, which may take the form of a merger, share exchange, asset purchase, stock acquisition, reorganization, or similar transaction. This targeted consolidation is specifically aimed at one or more entities within the vibrant life sciences industry. The corporation was formally established in 2021 and maintains its principal executive offices in New York, New York.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| BioPlus Sponsor LLC | C-Conversion | 5,749,999 | — | 2023-06-05 |
| BioPlus Sponsor LLC | J-Other | 380,000 | $10.00 | 2021-12-07 |
| BioPlus Sponsor LLC | J-Other | 0 | $10.00 | 2021-12-07 |
| BioPlus Sponsor LLC | 5,175,000 | — | 2021-12-02 | |
| Giovannetti Glen | 0 | — | 2021-12-02 |